Changing the Antibiotic Reimbursement Model to Encourage Drug Development Proliferation
November 12th 2023Although the current reimbursement model makes it difficult for pharmaceutical companies to recoup their investments, a subscription model like the prospective congressional bill, the Pasteur Act, may help change that paradigm. In addition, there are international measures being carried out that may bring about changes.
Watch
IDWeek Chair: “Come up With the Best Program Possible”
October 14th 2023Heather Yun, MD, FACP, FIDS who is this year’s IDWeek Chair for the Infectious Diseases Society of America (IDSA) talks about the honor of the position, the collective effort to put together the conference, and offers insights on AMR during war, as well as new emerging infectious disease threats.
Watch
How AI Can Improve Response Time to Potential Infectious Disease Outbreaks
September 26th 2023Toronto, Canada-based Bluedot offers surveillance tracking information to identify trends for viruses and syndromes efficiently to aid public health officials and other key stakeholders to assess situations and make decisions around this data.
Watch
Bacterial Infections in People With Cystic Fibrosis: A Race Against Time
September 7th 2023Patient advocate Ella Balasa has been living with cystic fibrosis her whole life. She experienced a multidrug resistant infection in 2019 and is speaking about her personal experiences at the World AMR Congress reminding people about the need to improve the antibiotic development paradigm.
Read More
Long-Acting HIV Injectable Preferable to Daily Oral Regimen
July 24th 2023A new study being presented at the ongoing IAS conference showed that people with HIV found the injectable therapy, Cabotegravir plus long-acting Rilpivirine (Cabenuva) is more conducive to today’s lifestyles, reduced stigma, and improved adherence.
Watch